Paradoxical Flare of Psoriasis after Ustekinumab Therapy
نویسندگان
چکیده
794 Ann Dermatol Received January 12, 2016, Revised September 24, 2016, Accepted for publication October 24, 2016 Corresponding author: Sik Haw, Department of Dermatology, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea. Tel: 82-31-910-7224, Fax: 82-31-910-7227, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology pISSN 1013-9087ᆞeISSN 2005-3894 Ann Dermatol Vol. 29, No. 6, 2017 https://doi.org/10.5021/ad.2017.29.6.794
منابع مشابه
Successful management of ustekinumab-induced pustular psoriasis without therapy discontinuation.
We present a 34-year-old female patient with methotrexate unresponsive longstanding plaque psoriasis who developed pustular psoriasis ten weeks after initiation of ustekinumab therapy. Given the lack of other side effects and the rapid initial response of the underlying plaque psoriasis, we opted against discontinuing ustekinumab therapy. Topical corticosteroids were added for the management of...
متن کاملUstekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
Erythrodermic psoriasis (EP) is a severe form of psoriasis precipitated by numerous factors, including physical stress, infections, and drugs. The disease represents a therapeutic challenge, and little is known about its response to ustekinumab. Though the efficacy of ustekinumab has been extensively studied in chronic plaque psoriasis, no trials have been carried out in EP. We report the case ...
متن کاملEmerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis
Correspondence: Shailendra Kapoor 2300 E Cary Street, Richmond, VA 23223, USA Email [email protected] I read with great interest the paper by Uhlenhake and Mehregan in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen increased use of ustekinumab in clinical applications other than psoriasis. For instance, ustekinumab i...
متن کاملPsoriasiform Eruption and Worsening of Pustulosis Palmoplantaris After Treatment with Two Anti-TNF-α Inhibitors, Followed by Successful Treatment with Ustekinumab
INTRODUCTION Tumor necrosis factor (TNF)-α inhibitors are widely used for the treatment of inflammatory diseases. One of the side effects of TNF-inhibitors is the development of a psoriatiform eruption, also known as paradoxical psoriasis. In this case report, we describe a patient with this side effect after treatment with adalimumab and etanercept. CASE REPORT A 45-year-old female was treat...
متن کاملUstekinumab in the therapy of chronic plaque psoriasis
Psoriasis is a chronic inflammatory disorder characterized by T cell dysregulation and a chronic inflammatory infiltrate within the epidermis. Several cytokines play an important role in the pathogenesis of psoriasis, including interleukin-12 (IL-12) and IL-23. These cytokines act via induction of pro-inflammatory cytokines which promote chronic inflammation and auto-reactivity. Ustekinumab is ...
متن کامل